Cancer is a dynamic multi-step, multi-mechanism disease involving complex interactive and redundant pathways, e.g. upregulation of survival pathways (e.g. bcl2, NFkB, AKT and receptor kinases) and genetic and epigenetic changes in relevant targets during cancer progression [20]. Here, BCL2 is linked to cancer.